|
Meisoindigo, an active compound of a Chinese anti-leukemia medicine, has
been effectively used in the treatment of chronic myelogenous leukemia (CML).
Increasing evidences have demonstrated that angiogenesis is an important
pathobiologic feature of CML. The anti-angiogenesis effect of meisoindigo on CML
is unknown.
|
[CML] A group of CMLHope.Com Subscribe: [EMAIL PROTECTED] Web Site: http://groups.cmlhope.com
